Couples Coping With Multiple Chronic Medical Conditions (GUGKS)

December 28, 2018 updated by: University of Zurich

Couples Coping With Multimorbidity: Does Solitary Expressive Writing Foster Psycho-social Adaptation?

Handling of complex health situations (as defined by multimorbidity) in partnership: communication between romantic partners; subjective illness perception; coping with stressful experiences due to multimorbidity.

Intervention : Expressive Writing about subjective illness perception vs. Writing about individual Time-Management Primary Endpoint: subjective Health (e.g. SF 12 questionnaire) Secondary Endpoints: Psychosocial Adjustments (Depression, somatic symptoms, quality of partnership and others)

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Coping in complex health situations (as defined by multimorbidity) and the role of relationship processes for psycho-social adaption: The study investigates interpersonal emotion regulation, disclosure, and illness perceptions in couples with a multimorbid patient. The intervention consists in 3 self-applied solitary written disclosure sessions (expressive writing), the control condition are 3 sessions writing about individual time-management (placebo).

Primary endpoint: subjective health (SF 12 questionnaire) Secondary endpoint: psychosocial adjustments (depression, positive and negative affect, somatic symptoms, adjustment disorder, marital satisfaction, sleep quality)

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • ZH
      • Zurich, ZH, Switzerland, 8091
        • University Hospital Zurich, Internal Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  • Age 18 or older
  • multimorbid condition (two or more chronic medical conditions)
  • patients living with romantic partner
  • very good oral and written command in German
  • written consent for participation by patient and partner

Exclusion criteria:

  • Pregnancy
  • Mini Mental State less than 26
  • Substance Abuse
  • Patients in Palliative Situation
  • Patients isolated due to infectious diseases
  • Patients participating in other clinical trials within the last 4 weeks before inclusion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: No Intervention
The control condition are 3 sessions writing about individual time-management (placebo).
The intervention consists in 3 self-applied solitary written disclosure sessions (expressive writing)
Active Comparator: Expressive Writing
The intervention consists in 3 self-applied solitary written disclosure sessions (expressive writing).
The intervention consists in 3 self-applied solitary written disclosure sessions (expressive writing)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Subjective health (SF-12)
Time Frame: 3 months
3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychosocial adjustments
Time Frame: 3 months
depression, positive and negative affect, somatic symptoms, adjustment disorder, marital satisfaction, sleep quality
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lukas Zimmerli, MD, University Hospital Zurich, Internal Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2013

Primary Completion (Actual)

April 1, 2017

Study Completion (Actual)

December 28, 2018

Study Registration Dates

First Submitted

July 24, 2013

First Submitted That Met QC Criteria

July 29, 2013

First Posted (Estimate)

July 30, 2013

Study Record Updates

Last Update Posted (Actual)

December 31, 2018

Last Update Submitted That Met QC Criteria

December 28, 2018

Last Verified

December 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • KEK-ZH 2013-0009_GUGKS

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Disease

Clinical Trials on Expressive Writing

3
Subscribe